Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. (Q53484159)

14 May 2018

title

Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. (English)

1 reference

14 May 2018

author name string

Kennedy AR

1

1 reference

14 May 2018

Szuhaj BF

2

1 reference

14 May 2018

Newberne PM

3

1 reference

14 May 2018

Billings PC

4

1 reference

14 May 2018

publication date

1 January 1993

1 reference

14 May 2018

published in

Nutrition and Cancer

1 reference

14 May 2018

volume

19

1 reference

14 May 2018

issue

3

1 reference

14 May 2018

page(s)

281-302

1 reference

14 May 2018

Protection against dimethylhydrazine-induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor.

cites work

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Inhibition of N-nitrosomethylbenzylamine-induced esophageal neoplasms by the Bowman-Birk protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

The conditions for the modification of radiation transformation in vitro by a tumor promoter and protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Pyrene acts as a cocarcinogen with the carcinogens benzo[a]pyrene, beta-propiolactone and radiation in the induction of malignant transformation in cultured mouse fibroblasts; soybean extract containing the Bowman-Birk inhibitor acts as an anticarci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

A serine protease activity in C3H/10T1/2 cells that is inhibited by anticarcinogenic protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Identification of a proteolytic activity which responds to anticarcinogenic protease inhibitors in C3H-10T1/2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Intestinal epithelial cells contain a high molecular weight protease subject to inhibition by anticarcinogenic protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Acute effects of the Bowman-Birk protease inhibitor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

C-myc expression is reduced in antipain-treated proliferating C3H 10T1/2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Cell cycle progression of C3H 10T1/2 and 3T3 cells in the absence of an increase in c-myc RNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

c-fos mRNA levels are reduced in the presence of antipain and Bowman-Birk inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Effects of protease inhibitors on c-myc expression in normal and transformed C3H 10T1/2 cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Chymotrypsin-specific protease inhibitors decrease H2O2 formation by activated human polymorphonuclear leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Effect of protease inhibitors on DNA amplification in SV40-transformed Chinese hamster embryo cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Protease inhibitors reduce the frequency of spontaneous chromosome abnormalities in cells from patients with Bloom syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Purification, partial characterization, and immunological relationships of multiple low molecular weight protease inhibitors of soybean

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Dietary habits and past medical history as related to fatal pancreas cancer risk among adventists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01635589309514259

10.1080/01635589309514259

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018